Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Molecular Determinants
100%
Exon 19
100%
Exon 20
100%
Specific Susceptibility
100%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
100%
Cetuximab
57%
Dimerization
42%
T790M mutation
42%
Aberrations
28%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
28%
Amino Acids
14%
Kinase Domain
14%
Duplication
14%
Codon
14%
Functional Consequences
14%
Protein Function
14%
Non-response
14%
Erlotinib
14%
Index Patient
14%
Structural Modeling
14%
Frame Insertion
14%
In Silico Modeling
14%
T790M
14%
Dimer Configurations
14%
Therapeutic Actionability
14%
Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Exon
100%
Non Small Cell Lung Cancer
100%
Cetuximab
50%
Amino Acid
12%
Epidermal Growth Factor Receptor Kinase Inhibitor
12%
Phosphotransferase
12%
Erlotinib
12%
Dimer
12%
In Silico
12%
Codon
12%
Phosphotransferase Inhibitor
12%
Epidermal Growth Factor Receptor Antibody
12%
Protein Function
12%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Exon
100%
Cetuximab
44%
Dimerization
33%
Kinase
22%
Phosphotransferase
22%
Codon
11%
Amino Acid
11%
Protein Function
11%
Erlotinib
11%
Neuroscience
Epidermal Growth Factor Receptor
100%
Exon
100%
Cetuximab
50%
Kinase
25%
Codon
12%
Amino Acid
12%
Protein Function
12%
Erlotinib
12%
Epidermal Growth Factor Receptor Antibody
12%